Compare Enveric Biosciences Inc (ENVB) vs SMX Security Matters plc (SMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs SMX Security Matters plc — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.69M), while SMX Security Matters plc trades at $3.72 (market cap $4.27M). The key difference: Enveric Biosciences Inc is the larger of the two by market cap, and SMX Security Matters plc is more actively traded (109,273 versus 41,141). Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and SMX Security Matters plc for 21 Days on average.
| ENVB | SMX | |
|---|---|---|
Market Cap | $6.69M | $4.27M |
Volume | 41,141 | 109,273 |
Sector | Health | Industrials |
52-Week High | $10.80 | $74.08K |
52-Week Low | $1.27 | $3.79 |
Typical Hold Time | 14 Days | 21 Days |
Enterprise Value | -$1.60M | -$27.06M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495, up 1.7% on the day, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten EPS expectations. Recent news includes a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in an investment conference.
The outlook remains speculative given the lack of revenue and negative profitability, but analyst consensus is bullish with 75% buy ratings. Key risks include the pre-revenue biotech model and dependence on successful drug development. Upside potential hinges on clinical progress and regulatory milestones for its psychiatric therapeutics pipeline.
SMX trades at $3.90, up 2.9% today, but technical indicators show a bearish trend with moving averages signaling sell. The company reported no revenue in 2025, with a net loss of $169.18 million and negative cash flow from operations. Recent news highlights SMX's focus on recycled plastic verification and digital material passports, gaining media attention from Forbes and Boston Herald in September-October 2026.
The outlook remains highly speculative given the absence of revenue and deep losses. Investment opportunity hinges on successful commercialization of its technology, but risks include cash burn, reliance on financing, and intense competition. Analyst sentiment is cautious due to weak fundamentals despite positive media coverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
